BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1950 related articles for article (PubMed ID: 15738862)

  • 1. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy.
    Rogóż Z
    Pharmacol Rep; 2013; 65(6):1535-44. PubMed ID: 24553002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The place of SSRIs in the treatment of schizophrenia].
    Zullino D; Delacrausaz P; Baumann P
    Encephale; 2002; 28(5 Pt 1):433-8. PubMed ID: 12386545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar disorder in adults with Asperger׳s Syndrome: a systematic review.
    Vannucchi G; Masi G; Toni C; Dell'Osso L; Erfurth A; Perugi G
    J Affect Disord; 2014 Oct; 168():151-60. PubMed ID: 25046741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar depression: issues in diagnosis and treatment.
    Thase ME
    Harv Rev Psychiatry; 2005; 13(5):257-71. PubMed ID: 16251165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressant and tolerance: Determinants and management of major side effects].
    David DJ; Gourion D
    Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into treatment-resistant depression. Psychotic symptoms, rather than unrecognized bipolar disorder, may underlie poor response.
    Harv Ment Health Lett; 2011 Mar; 27(9):6. PubMed ID: 21476247
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
    Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
    J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical depression: Clinical perspectives].
    Lutz M; Morali A; Lang JP
    Encephale; 2013 Sep; 39(4):258-64. PubMed ID: 23541919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Olanzapine in the treatment of depressive disorders with psychotic symptoms].
    Adli M; Rossius W; Bauer M
    Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.